Literature DB >> 25172874

Lipohypertrophy and the artificial pancreas: is this an issue?

Lutz Heinemann1, Larry Hirsch2, Roman Hovorka3.   

Abstract

Entities:  

Keywords:  artificial pancreas; injection sites; insulin action; lipohypertrophy; pharmacodynamics; pharmacokinetics

Mesh：

Year:  2014        PMID： 25172874      PMCID： PMC4455381          DOI： 10.1177/1932296814538941

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  12 in total

1.  Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors.

Authors:  Magdy A Omar; Ahmed A El-Kafoury; Ramy I El-Araby
Journal:  BMC Res Notes       Date:  2011-08-12

Review 2.  Continuous glucose monitoring and closed-loop systems.

Authors:  R Hovorka
Journal:  Diabet Med       Date:  2006-01       Impact factor: 4.359

3.  Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes.

Authors:  M Blanco; M T Hernández; K W Strauss; M Amaya
Journal:  Diabetes Metab       Date:  2013-07-22       Impact factor: 6.041

4.  Intramuscular risk at insulin injection sites--measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy.

Authors:  Laurence Hirsch; Karen Byron; Michael Gibney
Journal:  Diabetes Technol Ther       Date:  2014-10-20       Impact factor: 6.118

5.  Incidence of lipohypertrophy in diabetic patients and a study of influencing factors.

Authors:  Bahar Vardar; Sevgi Kizilci
Journal:  Diabetes Res Clin Pract       Date:  2007-02-15       Impact factor: 5.602

Review 6.  Insulin absorption from lipodystrophic areas: a (neglected) source of trouble for insulin therapy?

Authors:  Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2010-05-01

7.  Morphology of palpably abnormal injection sites and effects on absorption of isophane(NPH) insulin.

Authors:  J C Thow; A B Johnson; S Marsden; R Taylor; P D Home
Journal:  Diabet Med       Date:  1990-11       Impact factor: 4.359

8.  Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations.

Authors:  Michael A Gibney; Christina H Arce; Karen J Byron; Laurence J Hirsch
Journal:  Curr Med Res Opin       Date:  2010-06       Impact factor: 2.580

9.  Clinical factors influencing the absorption of 125I-NPH insulin in diabetic patients.

Authors:  K Kølendorf; J Bojsen; T Deckert
Journal:  Horm Metab Res       Date:  1983-06       Impact factor: 2.936

10.  Use of the site of subcutaneous insulin administration for the measurement of glucose in patients with type 1 diabetes.

Authors:  Stefan Lindpointner; Stefan Korsatko; Gerd Köhler; Hans Köhler; Roland Schaller; Ruthy Kaidar; Ofer Yodfat; Lukas Schaupp; Martin Ellmerer; Thomas R Pieber; Werner Regittnig
Journal:  Diabetes Care       Date:  2009-12-29       Impact factor: 17.152
View more
  3 in total

1.  Bruising-An Ignored Issue?

Authors:  Lutz Heinemann
Journal:  J Diabetes Sci Technol       Date:  2021-12-15

2.  Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes.

Authors:  Daniel J DeSalvo; David M Maahs; Laurel Messer; R Paul Wadwa; Shelby Payne; Trang T Ly; Bruce A Buckingham
Journal:  Diabetes Care       Date:  2015-08-25       Impact factor: 19.112

3.  Commentary: Why Was Inhaled Insulin a Failure in the Market?

Authors:  Jacob Oleck; Shahista Kassam; Jennifer D Goldman
Journal:  Diabetes Spectr       Date:  2016-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.